Evidence map›Paper›PMID 37080767›Full record

ArticleHeart (British Cardiac Society)2023

Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk.

Shishir Rao, Milad Nazarzadeh, Yikuan Li, Dexter Canoy, Mohammad Mamouei, Gholamreza Salimi-Khorshidi, Kazem Rahimi

Open access · hybridAbstract read
In one paragraph

Article in Heart (British Cardiac Society), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. A Proposed Checklist for Optimizing COPD Patient Discharge Processes in Italian Internal Medicine Wards.International journal of chronic obstructive pulmonary disease · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shishir RaoNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.ORCID 0000-0001-7331-9416
Milad NazarzadehNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
Yikuan LiNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
Dexter CanoyPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Mohammad MamoueiNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.ORCID 0000-0002-7757-5238
Gholamreza Salimi-KhorshidiNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
Kazem RahimiNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK kazem.rahimi@wrh.ox.ac.uk.
University of Oxford · GBNewcastle University · GB

Funding

British Heart Foundation FS/19/36/34346British Heart Foundation FS/PHD/21/29110British Heart Foundation PG/18/65/33872Department of Health
6 · The paper itself

Abstract

objectiveIn individuals with complex underlying health problems, the association between systolic blood pressure (SBP) and cardiovascular disease is less well recognised. The association between SBP and risk of cardiovascular events in patients with chronic obstructive pulmonary disease (COPD) was investigated. METHODS AND ANALYSIS: In this cohort study, 39 602 individuals with a diagnosis of COPD aged 55-90 years between 1990 and 2009 were identified from validated electronic health records (EHR) in the UK. The association between SBP and risk of cardiovascular end points (composite of ischaemic heart disease, heart failure, stroke and cardiovascular death) was analysed using a deep learning approach.

resultsIn the selected cohort (46.5% women, median age 69 years), 10 987 cardiovascular events were observed over a median follow-up period of 3.9 years. The association between SBP and risk of cardiovascular end points was found to be monotonic; the lowest SBP exposure group of <120 mm Hg presented nadir of risk. With respect to reference SBP (between 120 and 129 mm Hg), adjusted risk ratios for the primary outcome were 0.99 (95% CI 0.93 to 1.05) for SBP of <120 mm Hg, 1.02 (0.97 to 1.07) for SBP between 130 and 139 mm Hg, 1.07 (1.01 to 1.12) for SBP between 140 and 149 mm Hg, 1.11 (1.05 to 1.17) for SBP between 150 and 159 mm Hg and 1.16 (1.10 to 1.22) for SBP ≥160 mm Hg.

conclusionUsing deep learning for modelling EHR, we identified a monotonic association between SBP and risk of cardiovascular events in patients with COPD.

Indexed as

Cardiovascular DiseasesHypertensionPulmonary Disease, Chronic ObstructiveAgedAntihypertensive AgentsBlood PressureCohort StudiesFemaleHeart Disease Risk FactorsHumansMaleRisk FactorsAntihypertensive Agentsepidemiologyhypertension

Identifiers

PMID37080767
PMCPMC10423512
OpenAlexW4366588786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.